Illuminate Therapeutics
UEI: WVLWH6J17CP5
• CAGE: 9HSL5
Overview
Awardee Type
Parent
Name
Illuminate Therapeutics
Headquarters
Portola Valley, CA
United States
United States
Most Recent Award
Sept. 1, 2024
Calculating
Federal grant recipient
ILLUMINATE THERAPEUTICS, INC.
(UEI WVLWH6J17CP5, CAGE 9HSL5)
is headquartered in Portola Valley CA.
Its primary registered NAICS is 541713 Research and Development in Nanotechnology.
The corporation
was founded in April 2022 and
federally registered in
March 2023.
Federal Award Analysis
Illuminate Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ILLUMINATE THERAPEUTICS, INC.
UEI
WVLWH6J17CP5
CAGE Code
9HSL5
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 12, 2022
Initial Registration
March 13, 2023
Last Registration
Feb. 14, 2025
Registration Activation
Feb. 14, 2025
Registration Expiration
Feb. 12, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No